Plenty of collaborations and M&A deals being done in 2023 thus far .... where's our CLBP or CHF deal SI .... or is an acquisition on the cards now that we are so vulnerable ?
GLTAH
https://www.roi-nj.com/2023/08/29/h...ham-park-on-multi-year-cell-therapy-research/
Celularity and Regeneron to collaborate in Florham Park on multiyear cell therapy research
https://www.biospace.com/article/nine-billion-dollar-m-and-as-in-the-first-half-of-2023/
9 Top M&As in the First Half of 2023
https://www.pharmaceutical-technolo...-ma-activity-pharmaceutical-industry/?cf-view
M&A in pharmaceutical increased in Q2 2023
In the global pharmaceutical industry, there were 479 M&A deals announced in Q2 2023, worth a total value of $51bn, according to GlobalData’s Deals Database. The $10.8bn acquisition of prometheus biosciences by merck was the industry’s largest disclosed deal.
Ann: Mesoblast 2023 Full Year Financial Results Webcast, page-16
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |